247
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

The Effect of Daily Fluid Management and Beverages Consumption on the Risk of Bladder Cancer: A Meta-analysis of Observational Study

, , , , , , , , , , , & ORCID Icon show all
Pages 1217-1227 | Received 08 Apr 2018, Accepted 02 Aug 2018, Published online: 23 Dec 2018
 

Abstract

Epidemiological studies have evaluated the risk of bladder cancer (BCa) in relation to total fluid intake, as well as specific type of beverages consumption, with controversial results. The aim of this study was to further explore the potential relationship by conducting a meta-analysis. Fifty-four articles involving more than 43,000 BCa patients were included in this meta-analysis. A positive, though not statistically significant, association was found between total fluid intake and risk of BCa comparing the highest with lowest intake (SRRE: 1.16, 95%CI: 1.00–1.36). By conducting dose-response meta-analysis, we found that each 500 ml/day increase in total fluid intake was associated with 3.3% increased risk of BCa (RR: 1.03, 95%CI: 1.00–1.07). Pronounced increase in risk of BCa was detected when total fluid intake was more than 3000 ml/day. Meta-analyses of specific type of beverages showed increasing intake of coffee (RR: 1.03, 95%CI: 1.02–1.05) were risk factors for BCa. On the contrary, increasing intake of milk appeared to be a potential protective factor for BCa (RR: 0.90, 95%CI: 0.83–0.98). The risk of BCa was not significantly related to intake of water (RR: 1.01, 95%CI: 0.98–1.03), alcohol (RR: 1.01, 95%CI: 0.97–1.05), tea (RR: 1.01, 95%CI: 0.97–1.05) and soft drinks (RR: 1.04, 95%CI: 0.96–1.11).

Ethical approval

As the study was a meta-analysis based on the existing population-based studies, we did not apply for the approval of institutional review board.

Acknowledgments

The authors would like to thank all authors of the included studies in our meta-analysis.

Disclosure Statement

The authors declare that they have no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.